Patents by Inventor Craig Muldoon

Craig Muldoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11279733
    Abstract: There is provided a range of novel compounds. These novel compounds may demonstrate abroad spectrum antibacterial and antifungal activity. These compounds may be active against the emerging polymyxin resistant bacteria. These compounds may also be useful when used in conjunction with other pharmaceutically active agents.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: March 22, 2022
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Matthew Cooper, Mark Blaskovich, Alejandra Gallardo-Godoy, Karl Hansford, Alysha Elliott, Craig Muldoon, Bernd Becker
  • Publication number: 20200361994
    Abstract: There is provided a range of novel compounds. These novel compounds may demonstrate abroad spectrum antibacterial and antifungal activity. These compounds may be active against the emerging polymyxin resistant bacteria. These compounds may also be useful when used in conjunction with other pharmaceutically active agents.
    Type: Application
    Filed: November 2, 2018
    Publication date: November 19, 2020
    Inventors: Matthew COOPER, Mark BKASKOVICH, Alejandra GALLARDEO-GODLY, Karl HANSFORD, Slysha ELLOTT, Craig MULDOON, Bemd BECKER
  • Publication number: 20180187660
    Abstract: The present subject matter overcomes the deficiencies in the prior art by introducing or generating charged particles in an air stream and manipulating the air stream with magnetic fields operating on the charged particles. Embodiments of the present subject mater compress the air stream by accelerating charged particles with a moving magnetic field, where the magnetic field has a velocity perpendicular to its flux lines. The increased velocity of the charged particles increases the statistical mean particle velocity and thereby increases the pressure in the air stream. The compressed air stream is then heated and expanded through a second magnetic field. The expansion of the air stream substantially increases the velocity of the air stream and the charged particles therein. The interaction of the high velocity charged particles and the magnetic field imparts a force perpendicular to the flux lines, this force powers the movement of the magnetic field.
    Type: Application
    Filed: February 22, 2018
    Publication date: July 5, 2018
    Inventor: Patrick Craig Muldoon
  • Publication number: 20160032907
    Abstract: The present subject matter overcomes the deficiencies in the prior art by introducing or generating charged particles in an air stream and manipulating the air stream with magnetic fields operating on the charged particles. Embodiments of the present subject mater compress the air stream by accelerating charged particles with a moving magnetic field, where the magnetic field has a velocity perpendicular to its flux lines. The increased velocity of the charged particles increases the statistical mean particle velocity and thereby increases the pressure in the air stream. The compressed air stream is then heated and expanded through a second magnetic field. The expansion of the air stream substantially increases the velocity of the air stream and the charged particles therein. The interaction of the high velocity charged particles and the magnetic field imparts a force perpendicular to the flux lines, this force powers the movement of the magnetic field.
    Type: Application
    Filed: May 19, 2015
    Publication date: February 4, 2016
    Inventor: Patrick Craig Muldoon
  • Patent number: 9032705
    Abstract: The present subject matter overcomes the deficiencies in the prior art by introducing or generating charged particles in an air stream and manipulating the air stream with magnetic fields operating on the charged particles. Embodiments of the present subject matter compress the air stream by accelerating charged particles with a moving magnetic field, where the magnetic field has a velocity perpendicular to its flux lines. The increased velocity of the charged particles increases the statistical mean particle velocity and thereby increases the pressure in the air stream. The compressed air stream is then heated and expanded through a second magnetic field. The expansion of the air stream substantially increases the velocity of the air stream and the charged particles therein. The interaction of the high velocity charged particles and the magnetic field imparts a force perpendicular to the flux lines, this force powers the movement of the magnetic field and can also be extracted in the form of mechanical work.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: May 19, 2015
    Inventor: Patrick Craig Muldoon
  • Patent number: 8673586
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 1, 2012
    Date of Patent: March 18, 2014
    Assignee: Alchemia Limited
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Publication number: 20130011852
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 1, 2012
    Publication date: January 10, 2013
    Applicant: Alchemia Limited
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Patent number: 7989422
    Abstract: The present invention, in one aspect, provides a method of inhibiting bacterial growth by contacting bacteria with an effective amount of at least one monosaccharide compound of formula (1) as described herein:
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: August 2, 2011
    Assignee: Alchemia Limited
    Inventors: Wim Meutermans, Declan McKeveney, Johannes Zuegg, Rajaratnam Premraj, Craig Muldoon, Giang Thanh Le
  • Publication number: 20100089027
    Abstract: The present subject matter overcomes the deficiencies in the prior art by introducing or generating charged particles in an air stream and manipulating the air stream with magnetic fields operating on the charged particles. Embodiments of the present subject mater compress the air stream by accelerating charged particles with a moving magnetic field, where the magnetic field has a velocity perpendicular to its flux lines. The increased velocity of the charged particles increases the statistical mean particle velocity and thereby increases the pressure in the air stream. The compressed air stream is then heated and expanded through a second magnetic field. The expansion of the air stream substantially increases the velocity of the air stream and the charged particles therein. The interaction of the high velocity charged particles and the magnetic field imparts a force perpendicular to the flux lines, this force powers the movement of the magnetic field and can also be extracted in the form of mechanical work.
    Type: Application
    Filed: October 13, 2009
    Publication date: April 15, 2010
    Inventor: Patrick Craig Muldoon
  • Patent number: 7602096
    Abstract: The present subject matter overcomes the deficiencies in the prior art by introducing or generating charged particles in an air stream and manipulating the air stream with magnetic fields operating on the charged particles. Embodiments of the present subject matter compress the air stream by accelerating charged particles with a moving magnetic field, where the magnetic field has a velocity perpendicular to its flux lines. The increased velocity of the charged particles increases the statistical mean particle velocity and thereby increases the pressure in the air stream. The compressed air stream is then heated and expanded through a second magnetic field. The expansion of the air stream substantially increases the velocity of the air stream and the charged particles therein. The interaction of the high velocity charged particles and the magnetic field imparts a force perpendicular to the flux lines, this force powers the movement of the magnetic field and can also be extracted in the form of mechanical work.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: October 13, 2009
    Inventor: Patrick Craig Muldoon
  • Publication number: 20090023669
    Abstract: The present invention, in one aspect, provides a method of inhibiting bacterial growth by contacting bacteria with an effective amount of at least one monosaccharide compound of formula (1) as described herein:
    Type: Application
    Filed: December 20, 2006
    Publication date: January 22, 2009
    Applicant: Alchemia Limited
    Inventors: Wim Meutermans, Declan McKeveney, Johannes Zuegg, Rajaratnam Premraj, Craig Muldoon, Giang Thanh Le
  • Publication number: 20080280837
    Abstract: A method for inhibiting angiogenesis in a subject comprising administering to the subject at least one compound of General Formula (I), wherein the ring or any chiral center(s) may be of any configuration; Z is sulphur, oxygen, CH2, C(O), C(O)HN, NH, NRA or hydrogen, in the case where Z is hydrogen then R1 is not present, RA is selected from the set defined for R1 to R5, X and X? are independently oxygen or nitrogen providing that at least one X of General Formula (I) is nitrogen, X or X? may also combine independently with one of R1 to R5 to form an azide, R1 to R5 are independently selected from the following definition which includes but is not limited to H or an alkyl, acyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl substituent of 1 to 20 atoms, which is optionally substituted, and can be branched or linear, and R6 and R7 are hydrogen, or may combine to form a carbonyl function.
    Type: Application
    Filed: April 7, 2005
    Publication date: November 13, 2008
    Inventors: Judy Halliday, Wim Meutermans, Gerald Tometzki, Tracie E. Ramsdale, Johannes Zuegg, Bernd Becker, Craig Muldoon, Declan McKeveney, Rajaratnam Premraj, Glenn Condie
  • Publication number: 20080176815
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 19, 2007
    Publication date: July 24, 2008
    Applicant: ALCHEMIA LIMITED
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Publication number: 20080009418
    Abstract: A method of identifying biologically active compounds with defined selectivity profile comprises: (c) designing a library of compounds of formula (1) to scan molecular diversity; and (d) assaying the library of compounds in at least two different biological assays.
    Type: Application
    Filed: October 4, 2005
    Publication date: January 10, 2008
    Applicant: Alchemia LTD.
    Inventors: Gerald Tometzki, Wim Meutermans, Bernd Becker, Johannes Zuegg, Rajaratnam Premraj, Craig Muldoon, Declan McKeveney, Glenn Condie
  • Patent number: 7291623
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 5, 2003
    Date of Patent: November 6, 2007
    Assignee: Alchemia Limited
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Publication number: 20050209176
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 5, 2003
    Publication date: September 22, 2005
    Applicant: ALCHEMIA LIMITED
    Inventors: Wim Meutermans, Karl Schafer, Michael West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Patent number: 6694907
    Abstract: A shaped hull with a fixed angle keel with respect to the hull that when heeled, orients the keel to an angle of attack substantially related to the heel angle. The angle of attack being sufficient to create on the keel a lateral force substantially equal and opposite to the lateral force derived from the wind. The submerged portion of the hull, however, remains symmetrical and oriented parallel to the course sail as is its associated drag contribution vector. Thereby reducing or substantially eliminating the lateral force generated by the hull and the associated drag contribution. The movement of the shaped hull induces a lateral force on the keel without generating a lateral force and its associated drag on the hull, thus providing a sailboat with reduced drag without resorting to the prior art methods and their associated disadvantages.
    Type: Grant
    Filed: March 14, 2003
    Date of Patent: February 24, 2004
    Inventor: Patrick Craig Muldoon